MedTrace Logo

Rapid Diagnosis and Prognosis Recognition of Imaging and Biomarkers in Mild to Moderate Traumatic Brain Injury

NCT05108909 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2022-01-04

No results posted yet for this study

Summary

The investigators will carry out multi-center and large sample research based on the Chinese population, screen the optimal diagnostic and prognosis recognition biomarkers and analyze the diagnostic critical cutoff values in patients with mild to moderate traumatic brain injury, so as to provide a substantial basis for clinical diagnosis and prognosis recognition.

Conditions

  • MTBI - Mild Traumatic Brain Injury
  • Moderate Traumatic Brain Injury

Interventions

DEVICE

MRI, CT, and serum biomarkers

magnetic resonance image Imaging data were collected in a strong magnetic field, and collected the serum of participants.

Sponsors & Collaborators

  • Xi'an Jiaotong University

    collaborator OTHER

  • Second Affiliated Hospital of Wenzhou Medical University

    collaborator OTHER

  • Central South University

    collaborator OTHER

  • Xijing Hospital

    collaborator OTHER

  • First Affiliated Hospital Xi'an Jiaotong University

    lead OTHER

Principal Investigators

  • Ming Zhang, phD · First Affiliated Hospital of Xian Jiaotong University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2025-08-31
Completion
2025-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05108909 on ClinicalTrials.gov